SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028784
Filing Date
2022-08-09
Accepted
2022-08-09 16:42:07
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-10q_20220630.htm   iXBRL 10-Q 2955400
2 EX-31.1 abcl-ex311_8.htm EX-31.1 20971
3 EX-31.2 abcl-ex312_7.htm EX-31.2 20937
4 EX-32.1 abcl-ex321_6.htm EX-32.1 9460
5 EX-32.2 abcl-ex322_9.htm EX-32.2 9437
6 GRAPHIC gflfxvhuhguz000001.jpg GRAPHIC 35841
  Complete submission text file 0001564590-22-028784.txt   7692287

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA abcl-20220630.xsd EX-101.SCH 42695
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abcl-20220630_cal.xml EX-101.CAL 50698
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abcl-20220630_def.xml EX-101.DEF 137016
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20220630_lab.xml EX-101.LAB 335959
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20220630_pre.xml EX-101.PRE 254721
59 EXTRACTED XBRL INSTANCE DOCUMENT abcl-10q_20220630_htm.xml XML 1110884
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 221149031
SIC: 2834 Pharmaceutical Preparations